![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » WATSON AND UNIMED PHARMACEUTICALS, INC. SETTLE LAWSUIT OVER ANDROGEL TESTOSTERONE GEL
WATSON AND UNIMED PHARMACEUTICALS, INC. SETTLE LAWSUIT OVER ANDROGEL TESTOSTERONE GEL
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced that it has reached a settlement with Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and Laboratories Besins Iscovesco on outstanding patent litigation related to AndroGel 1% (testosterone gel) CIII, a topical testosterone replacement gel.
Drug Newswire (http://www.drugnewswire.com/5953/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct